EP Patent

EP0297436A2 — Treatment of hyperhidrosis and ichthyosis

Assigned to Individual · Expires 1989-01-04 · 37y expired

What this patent protects

Skin suffering from emotional hyperhidrosis, ichthyosis with or without keratosis, and intrinsic or photoaging wrinkling is treated with mono- or dicarboxylic acids containing 4 to 18 carbon atoms, or certain mercapto derivatives, salts or esters thereof.

USPTO Abstract

Skin suffering from emotional hyperhidrosis, ichthyosis with or without keratosis, and intrinsic or photoaging wrinkling is treated with mono- or dicarboxylic acids containing 4 to 18 carbon atoms, or certain mercapto derivatives, salts or esters thereof.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0297436A2
Jurisdiction: EP
Classification: —
Expires: 1989-01-04
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.